Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:epoetin_beta
|
| gptkbp:approvalYear |
1997
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
B03XA01
|
| gptkbp:contraindication |
uncontrolled hypertension
hypersensitivity to epoetin beta |
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
NeoRecormon
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Roche
|
| gptkbp:mechanismOfAction |
stimulates erythropoiesis
|
| gptkbp:pregnancyCategory |
gptkb:C_(AU)
|
| gptkbp:routeOfAdministration |
subcutaneous
intravenous |
| gptkbp:sideEffect |
hypertension
flu-like symptoms thromboembolic events |
| gptkbp:usedFor |
gptkb:anemia
chronic kidney disease chemotherapy-induced anemia |
| gptkbp:bfsParent |
gptkb:epoetin_beta
gptkb:F._Hoffmann-La_Roche_AG |
| gptkbp:bfsLayer |
7
|